CYPRIUM THERAPEUTICS
  • home
  • ABOUT
    • Management Team
    • Board of Directors
  • PIPELINE
    • About Menkes Disease
    • CUTX-101 (Copper Histidinate)
    • AAV-ATP7A Gene Therapy Development Pathway
    • Publications
    • Expanded Access Policy
  • Business Development
  • Investors & Media
    • Press Releases
    • Corporate Presentation
    • Resources
  • CONTACT US

Resources

Forms will be updated on a quarterly basis for the monthly dividends.

Form 8937 – January 31, 2023, February 28, 2023, and March 31, 2023

Corrected Final 2022 Form 8937

Corrected Final 2021 Form 8937

Corrected Final 2020 Form 8937

 

©2022 Cyprium Therapeutics

Privacy Disclaimer

2 Gansevoort Street, 9th Floor, New York, NY 10014


Website by Tidal Media Group